G. Steven Burrill
An introduction to Burrill Venture Capital
Flash required to view this video. Download the latest version here
G. Steven BurrillNews
Biotech takes a beating in market meltdown October 01, 2008 | Press Release
Biotech outperforms market in May June 02, 2008 | Press Release
Biotech Treads Water in April May 01, 2008 | Press Release
See all NewsBurrill Life Sciences III Advisory Board
Paul Berg—Cahill Professor in Biochemistry, Emeritus, Stanford University; Director, Emeritus, Beckman Center for Molecular and Genetic Medicine at Stanford; Nobel Laureate in Chemistry
Carl Feldbaum—President Emeritus, Biotechnology Industry Organization.
Frederick Frank—Vice Chairman and Director, Lehman Brothers.
Martin Gerstel—Chairman of Compugen, Keddem Bioscience and Evogene; Co-Chairman of Itamar Medical; former Co-Chairman and CEO of ALZA Corporation
Lee Hood—President of The Institute for Systems Biology
David M. Lawrence—Chairman and CEO (retired), Kaiser Foundation Health Plan and Hospitals
George Poste—CEO, Health Technology Networks; Director, The Biodesign Institute, Arizona State University; former CSTO and head of R&D, SmithKline Beecham
Tommy Thompson—Former Secretary of Health & Human Services; former Governor of Wisconsin; BLSCF II Advisory Board
